Clinical Trial: Multi-center Trial of Revlimid® and Rituximab for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Sponsor and Collaborators
Chronic Lymphocytic Leukemia Research Consortium
Contact: Mary Carpenter, CRC
Contact: Danelle F James, MD
Study Director: Thomas J Kipps, MD, PhD Director of the CLL Research Consortium and University of California San Diego
Principal Investigator: Danelle F James, MD, MAS CLL Research Consortium and University of California San Diego
Next post in Leukemia Clinical Trials
Log in to continue reading this article.
Don’t miss out on today’s top content on Oncology Nurse Advisor. Register for free and gain unlimited access to:
- Clinical Updates
- Evidence-Based Guidance
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
Want to read more?
Please login or register first to view this content.